Announcement Estrella Immunopharma, Inc., a leading clinical-level biopharmaceutical company establishing CD19 and CD22-focused ARTEMIS® T-cell therapies to provide treatment to autoimmune and cancer diseases, declared the completion of its second dose associate in the Phase 1 portion of its S...
Announcement Kisumu Governor Anyang’ Nyong’o has revealed the Kisumu County Wellness Screening Protocol/ FAITH MATETE, promising the wellness screening to be an important part of Kisumu’s health management system. This screening will cover routine checks for diabetes, cancer and ...
Announcement IntoCell Inc., a leading biotechnology company establishing linker technologies and next-generation payload for antibody-drug conjugates (ADCs) and Xcellon Biologics, a known US contract development and manufacturing organisation (CDMO), an excellence holder in critical biologics and ...
Announcement HUTCHMED Limited highlighted its business updates and research and development initiatives showcased during the R&D updates event held on 31st October 2025. The event witnessed HUTCHMED’s progress to date in bolstering immunology and innovative cancer treatments involving th...
Announcement Immunis, Inc., a clinical-level biotech establishing creative stem cell empowered biologics for disease and age-based immune dysregulation, has officially published peer-reviewed research in partnership with Dr Micah Drummond from the University of Utah. The discovery published in obe...
Announcement Forlong Biotechnology, a leading clinical-level biotech company, aims to establish a transitional change in cytokine therapies for extreme unmet needs for a certain patient group proudly declared that the first patient has been dosed in a phase 2 clinical trial investigating FL 115 in ...
Announcement The WebMD Ignite, the known strong full-service backup for organisations in the healthcare market, has introduced Ignite Pulsetm. The Ignite Pulsetm is an activation and accurate intelligence solution logically built to navigate healthcare marketers in this constrained budget and AI-c...
Announcement Vizient, the US-based, well-known, large healthcare performance improvement-focused company serving healthcare providers nationwide, applauded the US Food and Drug Administration (FDA) for taking action to advance biosimilar development and publishing new draft guidance. The latest dr...
Announcement PharmaDrug Inc., a leading speciality pharmaceutical company targeting the development, commercialisation and research of natural medicines, have entered a conclusive securities exchange agreement with Canurta Limited Partnership and its limited partners, said to be a parent entity of...
Image Credit: altius Announcement Altius, the AI boosted wellbeing infrastructure company run by Walmart executives Timothy State and David Hoke and former Humana, has signed a long-term contract with Syd Life AI, a UK-based leader in preventive health technologies. This partnership is for...
